期刊文献+

陕西汉族PCI术后人群CYP2C19基因多态性分析 被引量:2

Genetic polymorphism analysis of CYP2C19 in Shaanxi Han population after percutaneous coronary intervention
下载PDF
导出
摘要 目的描述陕西省汉族PCI术后人群的细胞色素2C19(CYP2C19)基因型分布特征。方法采用个体化基因诊断芯片技术对1 220例陕西汉族PCI术后人群进行CYP2C19基因分型检测。结果陕西汉族术后人群中男性野生基因型比例为34.02%(*1*1),突变杂合子基因型比例为33.61%(*1*2和1*3),突变纯合子基因型比例为9.43%(*2*2、*2*3和*3*3)。女性野生基因型比例为9.34%(*1*1),突变杂合子基因型比例为11.23%(*1*2和1*3),突变纯合子基因型比例为2.38%(*2*2、*2*3和*3*3)。结论陕西汉族PCI术后人群CYP2C19基因多态性以野生型纯合子*1*1和突变杂合子*1*2为主。 AIM To study the characteristics of CYF2C19 genotype in Shaanxi Han population after percu- taneous coronary intervention (PCI) and establish a foundation for individualized treatment. METHODS Genotyping of CYP2C19 in 1 220 Shaanxi Han patients after PCI were determined by gene chip. RESULTS According to genotyping results, the frequencies of wild type (WT) * 1 * 1 in Shaanxi Han population were 34.02%, WT '1"2 and "1"3 were 33.61%, and WT *2*2, *2*3 and *3 *3 were 9.43% in males. The frequencies of WT * 1 * 1 were 9.34% , WT * 1 *2 and * 1 *3 were 11.23% , and WT* 2 * 2, * 2 * 3 and * 3 * 3 were 2.38% in females. CONCLUSION Genetic polymorphism analysis of CYP2C19 WT * 1 * 1 and * 1 * 2 in Shaanxi Han population after PCI are most frequent.
出处 《心脏杂志》 CAS 2016年第4期439-442,共4页 Chinese Heart Journal
关键词 细胞色素2C19 基因多态性 陕西汉族 氯吡格雷 CYP2C19 genetic polymorphism Shaanxi Han population clopidogrel
  • 相关文献

参考文献3

二级参考文献47

  • 1张健,朱晓东,卫敏刚,唐跃年,蒋樾廉,陈伦,刘海涛.上海市544例学龄儿童CYP3A酶活性分布初探[J].中国药房,2005,16(20):1560-1562. 被引量:7
  • 2周健,吕虹,康熙雄.中国汉族人群不同性别、年龄、体重指数之间细胞色素氧化酶CYP2C19基因多态性的检测[J].中国临床药理学与治疗学,2007,12(2):208-213. 被引量:84
  • 3Mega J L,Close S L,Wiviott S D,et al.Cytochrome p450 polymorphisms and response to clopidogrel[J].N Engl J Med,2009,360(21):354-62.
  • 4Angiolillo D J.Variability in responsiveness to oral antiplatelet therapy[J].Am J Cardiol,2009,103(3 Suppl):27-43.
  • 5Halushka M K,Walker L P,Halushka P V.Genetic variation in cyclooxygenase 1:effects on response to aspirin[J].Clin Pharmacol Ther,2003,73(1):122-30.
  • 6Gurbel P A,Bliden K P,DiChiara J,et al.Evaluation of dose-related effects of aspirin on platelet function:results from the aspirin induced platelet effect(ASPECT)study[J].Circulation,2007,115(25):3156-64.
  • 7Maree A O,Curtin R J,Chubb A,et al.Cyclooxygenase-1 haplotype modulates platelet response to aspirin[J].J Thromb Haemost,2005,3(10):2340-5.
  • 8Gonza′lez-Conejero R,Rivera J,Corral J,et al.Biological assessment of aspirin efficacy on healthy individuals:heterogeneous response or aspirin failure[J]?Stroke,2005,36(2):276-80.
  • 9Papafili A,Hill M R,Brull D J,et al.Common promoter variant in cyclooxygenase-2 represses gene expression:evidence of role in acute-phase inflammatory response[J].Arterioscler Thromb Vasc Biol,2002,22(10):1631-6.
  • 10Angiolillo D J,Ferna′ndez-Ortiz A,Bernardo E,et al.Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel[J].Arterioscler Thromb Vasc Biol,2006,26(8):1895-900.

共引文献97

同被引文献18

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部